Collateral cardiovascular damage during the COVID-19 pandemic

Care pathways for ST-segment elevation myocardial infarction (STEMI) were interrupted during the coronavirus disease 2019 (COVID-19) pandemic. A new cardiac MRI study has revealed that increased total ischaemic time for patients with STEMI during major public health restrictions was associated with increased infarct size and other markers of myocardial damage.

Automated summary

Research has shown that increased total ischaemic time for STEMI patients during the COVID-19 pandemic was linked to larger infarct size and elevated markers of myocardial damage.